Inspired by the genotypes of commonly used BRAFV600E-mutant CRC cell lines [10], which carry p53 and/or WNT-pathway mutations and represent prime examples for complete niche autonomy, we asked whether these alterations would rescue BRAFV600E-induced organoid disintegration. The gene discussed is TP53; the disease is colorectal carcinoma.